前收市價 | 2.9500 |
開市 | 2.9000 |
買盤 | 2.5000 |
賣出價 | 2.7000 |
拍板 | 72.50 |
到期日 | 2024-06-21 |
今日波幅 | 2.5100 - 3.1000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 10.05k |
Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.